| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/19/2008 | EP1899381A1 Immobilisation of polypeptides by irradiation |
| 03/19/2008 | EP1899371A2 Method for preparing a covalently cross linked oligomer of amyloid beta peptides |
| 03/19/2008 | EP1899363A1 Method for identifying modulators of rufy2 useful for treating alzheimer's disease |
| 03/19/2008 | EP1898955A2 Polymer-based compositions and conjugates of non-steroidal anti-inflammatory drugs |
| 03/19/2008 | EP1898954A1 Composition and dosage form comprising a solid or semi-solid matrix |
| 03/19/2008 | EP1898937A1 Heparin coating of biological tissue |
| 03/19/2008 | EP1898883A2 Complexation of metal ions with polypeptides |
| 03/19/2008 | EP1898880A2 Gel compositions for topical administration |
| 03/19/2008 | EP1898873A1 Gelatin-containing topical composition |
| 03/19/2008 | EP1898832A1 Fast degrading polymers |
| 03/19/2008 | EP1581210B1 Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor |
| 03/19/2008 | EP1575577A4 Composition for the prevention and treatment of inflammation of the ear |
| 03/19/2008 | EP1496876B1 Aerosol formulation for inhalation comprising tiotropiumbromide |
| 03/19/2008 | EP1469848B1 Sedative non-benzodiazepine formulations |
| 03/19/2008 | EP1453487B1 Pharmaceutical dosage form with multiple coatings |
| 03/19/2008 | EP1429792B1 Strontium compound for treatment of sub-dermal soft tissue pain |
| 03/19/2008 | EP1429725B1 Ophthalmic depot formulations for periocular or subconjunctival administration |
| 03/19/2008 | EP1353668B1 Processes for the preparation of pharmaceutical preparations containing epothilone analogues for the treatment of cancer |
| 03/19/2008 | EP1280604B1 Media milling |
| 03/19/2008 | EP1232753B1 Stable protein solution filled in a container made from a hydrophobic resin and method of stabilizing the same |
| 03/19/2008 | EP1200137B1 Agent for occluding blood vessels |
| 03/19/2008 | EP0980240B1 Sustained-release compositions and method for preparing same |
| 03/19/2008 | EP0652766B2 Human growth hormone aqueous formulation |
| 03/19/2008 | CN101146543A Light pharmaceutical water and therapeutic compositions and preparation methods thereof |
| 03/19/2008 | CN101146524A A transdermal topical composition and its uses |
| 03/19/2008 | CN101146517A Methods and systems for operating an aerosol generator |
| 03/19/2008 | CN101143920A Copolymer and cross linking compound for unsaturated anhydride or unsaturated imide and cyclic lactone |
| 03/19/2008 | CN101143221A Central airway administration for systemic delivery of therapeutics |
| 03/19/2008 | CN101143220A Hydrogenated castor oil nano-lipophilic medicine preparation and preparation method thereof |
| 03/19/2008 | CN101143219A Medical tool for treating cervical erosion |
| 03/19/2008 | CN101143218A Medical tool for treating cervical erosion |
| 03/19/2008 | CN101143212A Recombination human acidic mechanocyte growth factor temperature sensitive type gel preparation and preparation method thereof |
| 03/19/2008 | CN101143175A New jinji preparation for treating male and female pelvic inflammation and production method thereof |
| 03/19/2008 | CN101143173A Capsule for treating acute dysentery and acute diarrhea and its preparation method |
| 03/19/2008 | CN101143154A Method for preparing surface cladding super-micro traditional Chinese medicine material crude slice |
| 03/19/2008 | CN101143144A Milrinone lactate freezing-dried powder injection and preparation method thereof |
| 03/19/2008 | CN101143142A Silybin supersaturated self-emulsion composition and preparation method thereof |
| 03/19/2008 | CN101143140A Isosorbide mononitrate timely quick-release and slow-release preparation |
| 03/19/2008 | CN101143139A Stable tiopronin injection and preparation method thereof |
| 03/19/2008 | CN101143133A Sodium fusidate freezing-dried powder injection |
| 03/19/2008 | CN101143132A Method for preparing high content beta-carotene water soluble nanometer particles |
| 03/19/2008 | CN101143129A Methotrexate intravenous emulsion and its preparation method |
| 03/19/2008 | CN101143128A Strong-absorbent slow release external-applied tincture plaster or ointment |
| 03/19/2008 | CN101143126A Ethyl cellulose slow release system for nucleophilic NO donor medicine and its preparation method |
| 03/19/2008 | CN100375636C Use of saccharide composition with protection on microecologic prepn |
| 03/19/2008 | CN100375635C Water soluble anti-cancer medicine slow-release fiber preparation and preparing method therefor |
| 03/18/2008 | US7345138 Biodegradable polyphosphates for controlled release of bioactive substances |
| 03/18/2008 | US7345093 Methods of enhancing solubility of compounds |
| 03/18/2008 | US7345023 Treatment of hyperproliferative conditions of body surfaces |
| 03/18/2008 | US7344887 Methods and products for delivering biological molecules to cells using multicomponent nanostructures |
| 03/18/2008 | US7344699 Drug conjugate comprising an erythropoietin receptor ligand and an anticancer agent |
| 03/18/2008 | US7344698 Emulsion containing nanoparticles in perfluorohydrocarbon solvent; antiinflammatory agents; antitumor agents |
| 03/18/2008 | CA2507743C Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles |
| 03/18/2008 | CA2401005C Methods for extraction and reaction using supercritical fluids |
| 03/18/2008 | CA2389167C Pharmaceutical formulations of resveratrol and methods of use thereof |
| 03/18/2008 | CA2382359C Pharmaceutical preparation containing nanosol |
| 03/18/2008 | CA2379331C Ectoparasiticidal aqueous suspension formulations of spinosyns |
| 03/18/2008 | CA2355776C Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents |
| 03/18/2008 | CA2355239C Pharmaceutical formulations |
| 03/18/2008 | CA2355186C Process for producing polymer |
| 03/18/2008 | CA2347195C Oral pharmaceutical compositions containing buprenorphin |
| 03/18/2008 | CA2341976C Fish gelatinous composition for use as an ingredient in tablets |
| 03/18/2008 | CA2329128C Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/18/2008 | CA2320430C Recombinant mistletoe lectins |
| 03/18/2008 | CA2319359C Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers |
| 03/18/2008 | CA2315395C Compositions and methods for treatment of alopecia |
| 03/18/2008 | CA2303852C Fish gelatin compositions containing a hydrocolloid setting system |
| 03/18/2008 | CA2275889C Formulation and method for treating neoplasms by inhalation |
| 03/18/2008 | CA2266781C Piperazine based cytofectins |
| 03/18/2008 | CA2266645C Polycarboxylic based cross-linked copolymer |
| 03/18/2008 | CA2211677C Taste masking liquids |
| 03/18/2008 | CA2166102C Redirection of cellular immunity by receptor chimeras |
| 03/18/2008 | CA2106105C Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| 03/18/2008 | CA2102494C A pharmaceutical composition containing a defined lipid system |
| 03/18/2008 | CA2015060C Novel antibody delivery system for biological response modifiers |
| 03/14/2008 | CA2568354A1 Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| 03/13/2008 | WO2008031105A1 Polymeric guanidine salt-based germicides |
| 03/13/2008 | WO2008031087A1 Compositions comprising a c2-c14 carboxylic acid and a surfactant for treating hoof diseases |
| 03/13/2008 | WO2008030557A2 Compositions and methods for enhancing transport through mucus |
| 03/13/2008 | WO2008030359A2 Topical compositions |
| 03/13/2008 | WO2008030134A1 Method for producing microcapsulated medicinal substances in the form of micronised water-dispersible powders and pastes |
| 03/13/2008 | WO2008029909A1 Composition comprising reduced coenzyme q10 and lysolecithin |
| 03/13/2008 | WO2008029908A1 Stable lyophilized pharmaceutical preparation comprising antibody |
| 03/13/2008 | WO2008029763A1 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 03/13/2008 | WO2008029698A1 Copolymer and method of producing the same |
| 03/13/2008 | WO2008029282A2 Aqueous formulation comprising an antitumor agent |
| 03/13/2008 | WO2008029208A1 Use of polyols to obtain stable polymorphous forms of rifaximin |
| 03/13/2008 | WO2008028667A2 Use of glycolipids as adjuvants |
| 03/13/2008 | WO2008028547A1 Liquid composition for prevention and/or treatment of different bone metabolic diseases, uses thereof, and preparation process therefore |
| 03/13/2008 | WO2008028530A1 Compounds as aptamer-dimers and their uses in diagnosis and therapy |
| 03/13/2008 | WO2008028347A1 Combined antibiotics preparation |
| 03/13/2008 | WO2008007383A8 Dried electrified hydrocolloid gels having unique structure and porosity |
| 03/13/2008 | WO2008003321A3 Compositions with several hyaluronic acid fractions for cosmetic use |
| 03/13/2008 | WO2007147902A3 Rehydratable pharmaceutical product |
| 03/13/2008 | WO2007147445A3 Keratin-binding effector molecules, and method for the production thereof |
| 03/13/2008 | WO2007147372A3 Pharmaceutical composition for administration by injection |
| 03/13/2008 | WO2007143381A3 Microparticles and methods for production thereof |
| 03/13/2008 | WO2007138324A3 Materials and complexes for the delivery of biologically-active material to cells |
| 03/13/2008 | WO2007129329A3 Extended release pharmaceutical formulation comprising venlafaxine hydrochloride |
| 03/13/2008 | WO2007123872A3 Polyesteramide platform for site specific drug delivery |